
Twelve years of multiples investors have paid for Indogulf Cropsciences Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Indogulf Cropsciences Ltd trades at a P/E of 9.02× and P/B of 0.67×.
Twelve years of audited numbers for Indogulf Cropsciences Ltd, switchable between annual and quarterly views, consolidated or standalone.
Indogulf Cropsciences Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹355.89 Cr and reported EPS of ₹6.72.
| Period | 2025 | 2026 |
|---|---|---|
| Revenue from Operations | 590 | 705 |
| Other Income | 4 | 7 |
| Total Income | 594 | 712 |
| Cost of Goods Sold (COGS) | 415 | 486 |
| Gross Profit | 176 | 218 |
| +Operating Expenses | 112 | 144 |
| EBITDA | 64 | 74 |
| +Non-Operating Expenses | 26 | 29 |
| Profit Before Tax (PBT) | 45 | 53 |
| +Tax Expense | 13 | 13 |
| Profit After Tax (PAT) | 31 | 40 |
| Earnings Per Share (EPS) | 6.45 | 6.33 |
| Diluted Shares Outstanding (Nos.) | 4 | 6 |
| +Additional Disclosures | 966 | 1,146 |
| Sales Growth % | — | 19.34 |
| YoY Sales Growth % | — | 19.34 |
| Material Cost % | 77 | 73 |
| Employee Cost % | 8 | 8 |
| Other Cost % | 11 | 12 |
| OPM % | 11 | 11 |
| Tax % | 29 | 25 |
| Profit Growth % | — | 27.18 |
| Gross Margin % | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 |
| Additional Fields | 54 | 63 |
Disclosed business segments at Indogulf Cropsciences with their share of revenue and profit, switchable between consolidated and standalone reporting.
Indogulf Cropsciences discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Indogulf Cropsciences Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Indogulf Cropsciences Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
The company reported exceptional quarterly profit growth of 657.00% and robust sales growth of 43.30% in the latest quarter, indicating strong operational momentum and demand for its products.
Promoter holding remains substantial at 69.05% as of September 2025, reflecting significant confidence from the core management in the company's long-term prospects and stability.
With a P/E ratio of 19.90, IGCL appears more attractively valued compared to many industry peers, whose P/E ratios often exceed 30-40, suggesting potential for re-rating.
The debt-to-equity ratio of 0.69 indicates a manageable level of debt, suggesting a relatively healthy financial structure and lower risk compared to highly leveraged companies.
A Return on Capital Employed (ROCE) of 14.80% demonstrates the company's efficiency in generating profits from its capital, which is a positive indicator for investors.
Promoter holding sharply decreased from 96.86% in June 2025 to 69.05% in September 2025, which could raise concerns about insider confidence or potential share dilution.
The company has a 0.00% dividend yield, indicating it currently does not distribute profits to shareholders, which might deter income-focused investors seeking regular payouts.
A reported book value of 0.00 is highly unusual and suggests either missing data or a fundamental issue in asset valuation, requiring further clarification for investors.
The stock has shown recent negative movement, with a -1.97% change on Oct 30 and trading near its 52-week low of 91.00, indicating potential investor apprehension.
Despite recent strong growth, net profit has fluctuated significantly, from 12.94 Cr (Mar 2024) to 1.35 Cr (Jun 2024) before recovering to 3.87 Cr (Jun 2025), suggesting inconsistency.
Trim if P/E re-rates above 12. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 40.36. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Indogulf Cropsciences Ltd is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Indogulf Cropsciences Ltd — derived from the live tape, not yesterday's close.
Indogulf Cropsciences Ltd last traded at ₹60.64 with an intraday range of ₹56.12–₹62.39 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 75.85 | +15.21 | +25.09% |
| R3 | 69.58 | +8.94 | +14.75% |
| R2 | 65.99 | +5.35 | +8.82% |
| R1 | 63.31 | +2.67 | +4.41% |
| PIVOT | 59.72 | -0.92 | -1.52% |
| CURRENT | 60.64 | — | — |
| S1 | 44.50 | -16.14 | -26.61% |
| S2 | 50.77 | -9.87 | -16.27% |
| S3 | 53.45 | -7.19 | -11.86% |
| S4 | 57.04 | -3.60 | -5.93% |
IGCL is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 57.38 ~ 57.79
Trading Above opening range, showing Bullishness
Daily traded volume and delivery percentage for Indogulf Cropsciences Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Indogulf Cropsciences Ltd stood at 50.9% of traded volume, against a 20-day average of 59.3%.
Filings Indogulf Cropsciences sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Indogulf Cropsciences files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 78 documents below.
Indogulf Cropsciences Limited has informed the Exchange about Transcript
Indogulf Cropsciences Limited has informed the Exchange about Link of Recording
Indogulf Cropsciences Limited has informed the Exchange about Copy of Newspaper Publication
Indogulf Cropsciences Limited has informed the Exchange about Schedule of meet
Monitoring Agency Report and Statement of Deviation or Variation Report for the quarter and year ended March 31, 2026
Every dividend, stock split and bonus issue Indogulf Cropsciences has declared, sequenced by announce and record date.
Indogulf Cropsciences corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Indogulf Cropsciences Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Indogulf Cropsciences Ltd operates in the Basic Materials, listed as NSE: IGCL, BSE: 544432.

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Indogulf Cropsciences Ltd (IGCL) is ₹60.64. Today, the stock has gained by ₹4.79 (8.58%), trading in a range of ₹56.12 to ₹62.39. The stock opened at ₹57.79 with a trading volume of 1,51,855 shares.
Indogulf Cropsciences Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹355.89 crores, P/E ratio of 9.02, ROE of 10.90%, and ROCE of 14.80%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Indogulf Cropsciences Ltd (IGCL) is ₹0, while the 52-week low is ₹0. Currently trading at ₹60.64, the stock is Infinity% away from its 52-week low and -Infinity% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Indogulf Cropsciences Ltd stock at ₹60.64 depends on multiple factors. The stock is currently trading with a P/E ratio of 9.02 and P/B ratio of 0.67. Today's performance shows a gain of 8.58%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Indogulf Cropsciences Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹60.64, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Indogulf Cropsciences Ltd's key financial metrics include: P/E Ratio: 9.02, P/B Ratio: 0.67, ROE: 10.90%, ROCE: 14.80%, Dividend Yield: 0.00%, EPS: ₹6.72, Book Value: ₹90.98, and Debt-to-Equity: 39.86. The company's market cap stands at ₹355.89 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Indogulf Cropsciences Ltd stock opened at ₹57.79 and is currently trading at ₹60.64, showing a gain of ₹4.79 (8.58%). The intraday high is ₹62.39 and low is ₹56.12. The trading volume stands at 1,51,855 shares, indicating moderate market participation today.
Indogulf Cropsciences Ltd has a Price-to-Earnings (P/E) ratio of 9.02, which means investors are willing to pay ₹9.02 for every ₹1 of earnings. With an EPS of ₹6.72, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Indogulf Cropsciences Ltd (IGCL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.